arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Chemours Co

CC
$15.75 ▲ +0.64 (+4.24%) at close
Materials ·Chemicals & Allied Products ·USChemicals & Allied Products
50 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
12
Health
Poor
Bearish
auto_awesome

Analytical Summary

Chemours Co faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.4B
Dividend Yield 0.56%
Revenue Growth 1.0%
Op. Margin
ROIC
FCF / Share $-0.62
Trailing P/E
Price / Book 11.0x
FCF Yield
Debt / Equity 19.07
info Valuation on last close. End-of-day price, Aug 7, 2026.

50-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.38B
↑ +1.0%
Net Income Profit after all expenses
$-29.00M
↓ -625.0%
FCF / Share Free cash flow per share
$-0.62
↑ +52.8%
Long-Term Debt Long-term obligations
$4.10B
— -0.1%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
24
Returns
5
Financial Health
2
Cash Quality
18

Dividend History

Dividend / share · sourced from SEC filings
$0.51 Latest / share
-48.8% YoY
-1.2% 11-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 13 years · 50 quarters